(3S,9R,16S,19R,22S,25S,31S,32R)-31-((S)-2-((R)-4-amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-3-carboxypropanamido)-3-(2-(2-aminophenyl)-2-oxoethyl)-25-(3-aminopropyl)-22-(carboxymethyl)-6-((R)-1-carboxypropan-2-yl)-9-(hydroxymethyl)-19,32-dimethyl-2,5,8,11,14,18,21,24,27,30-decaoxo-1-oxa-4,7,10,13,17,20,23,26,29-nonaazacyclodotriacontane-16-carboxylic acid
Daptomycin beta-Isomer is a fully characterized chemical compound used as a reference standard of API Daptomycin. The standard offered is compliant with regulatory guidelines. Daptomycin beta-Isomer is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 123180-72-3
Related products
Daptomycin Impurity 33 (Daptomycin beta-isomer diastereomer, Acetate Salt)
M.F. -
M.W. 1620.69; 59.04
CAT# AR-D06105
CAS# NA
Daptomycin Impurity 28 (linear Daptomycin impurity, Acetate Salt)
M.F.
M.W. 1638.71; 59.04
CAT# AR-D06100
CAS# NA
